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Abstract
Left ventricle outflow tract obstruction is a relatively common form of congenital heart 
disease, occurring in 2.8 out of 10,000 live births and accounts for 3-6% of congenital 
heart diseases. Subvalvular aortic stenosis can be either a fixed stenosis resulting from 
subaortic membrane or a dynamic stenosis because of hypertrophic cardiomyopathy. 
We described an original and rare image of double orifice fissured subaortic membrane 
in the adult.











Int J Cardiovasc Pract. 




Left ventricular outflow tract obstructions (LVOTOs) encom-
pass a series of stenotic lesions starting in the anatomic left ven-
tricular outflow tract (LVOT) and stretching to the descend-
ing portion of the aortic arch. Obstruction may be subvalvular, 
valvular, or supravalvular [1-4]. Fixed subaortic stenosis may 
be due to a discrete fibrous membrane, a muscular narrowing, 
or a combination of them. The obstruction may be focal, as in 
a discrete membrane, or more diffused, resulting in a tunnel 
leading out of the left ventricle (Table 1).
The fibromuscular fixed subaortic stenosis is the most fre-
quent, and in many cases the tunnel-type lesions are asso-
ciated with a greater degree of stenosis. They are isolated or 
acquired and their prevalence in adults with congenital heart 
disease is 6.5%, with a male to female ratio of 2:1 [4-7]. We 
reported an interesting and reliable case of double orifice 
fixed subaortic membrane in adults.
CASE PRESENTATION
A 55-year-old Caucasian female with a 6-month clinical histo-
ry of breathlessness and mild fatigue referred for presumptive 
aortic stenosis to our EchoLab. The first transthoracic echo-
cardiogram (TTE) revealed a thickened aortic cusp with a mild 
stenosis (Effective Orifice Area [EOA] 1.7 cmq, Mean Aor-
tic Valve Pressure Gradient [MAVPG] 20 mmHg, Doppler

















Velocity Index [DVI] 0.57) and a mild regurgitation. A phys-
ical examination documented a 3/6 systolic ejection murmur 
and no basilar rales; the blood pressure was 130/80 mmHg. 
The transesophageal echocardiography (TEE) revealed 
a normal aortic morphology (tricuspid, Fig 1a), but high
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Figure 1: Ttransesophageal echocardiography (a) revealing the normal tricuspid morphology and the high systolic flow velocity in the left 
ventricular outflow tract (LVOT, whit arrow) a sign of vascular turbulence due to a suspicious and linear structure detected in the LVOT (c, 
arrow). The three-dimensional TEE highlighted the spatial assessment of the sub-aortic membrane (d, arrow), in particularly the sub-aor-
tic membrane was fissured in its upper portion (e) and the color Doppler documented the flow coming through fenestrations (f, double 
orifice).
systolic flow velocity in the left ventricular outflow tract 
(LVOT) with documented evidence of turbulence on co-
lour-Doppler images (Fig 1b).
Due to progressive diagnostic examination, a suspicious and 
linear structure could be detected in the LVOT, about 5 mm 
below the aortic valve: a sub-aortic membrane (Fig 1c, ar-
row). Live three-dimensional TEE (3D-TEE, using a fully 
sampler 3D transducer, Philips IE 33, Handover) improved 
the spatial assessment of the sub-aortic membrane (Fig 1d). 
On the other hand, using multiplanar review on Xcelera work-
station with the use of QLab software (Philips Medical Sys-
tems), the sub-aortic membrane was better analyzed: it was 
fissured in its upper portion (Fig 1e) and the color Doppler 
documented the flow coming through fenestrations (double 
orifice, Fig 1f). Videos are available as online supplements. 
The patient was enrolled for yearly follow-up echocardiog-
raphy and treated with low dose beta-blocker (Bisoprolol).
DISCUSSION
Subaortic stenosis carries considerable morbidity and mor-
tality and some of these patients could progress to develop 
severe stenosis and aortic regurgitation [8]. Patients with 
subaortic stenosis could present no signs or symptoms of 
chest pain, syncope and congestive heart failure depending 
of the severity of obstruction. According to Ayoub et al. [9], 
misdiagnosis and failure to recognize fixed left ventricular 
outflow tract lesions (such as subvalvolar aortic stenosis due 
to membrane) may result in morbidity as a result of inap-
propriate therapy and delay of definitive surgical treatment. 
Hence, it is necessary to identify the correct type and level 
of obstruction in the LVOT by careful correlation of clinical 
examination, by Doppler evaluation, and advanced imaging 
findings. The 2-D Echocardiogram is the primary diagnostic 
method for diagnosing subaortic stenosis and distinguishing 
a discrete fibrous membrane from diffuse fibromuscular type 
of obstruction. The 3-D Echocardiogram could be the gold 
standard for the detection of LVOT obstruction and their dif-
ferential diagnosis because of the accuracy, specificity of the 
images, and the definition of the cardiac details. The 3-D view 
of the heart addresses a better comprehension of the anatom-
ical and functional LVOT obstruction in order to program 
the best therapeutic choice. Computed tomography could 
help to collect further information of the hemodynamic de-
tails of obstruction and its relationships with the surrounding 
anatomical structures. Furthermore, cardiac MRI is a reliable 
and useful support to identify the type of LVOT obstruction 
and cardiac chambers characteristics. As a supplement to 
them, if the diagnosis was still doubtful, we suggest intra-car-
diac echocardiogram (ICE) [10].
According to ESC Guidelines for the management of grown-
up congenital heart disease (2010) [11], the therapeutic 
choice of subaortic stenosis could depend to the degree of 
severity, mean gradient, and continuity equation-calculated 
effective orifice area (AVA). Medical therapy could be for 
inoperable patients and to control heart failure. Surgery is 
required in symptomatic patients; in selected adolescents 
and young adults with non-calcified valves, balloon valvu-
loplasty may be considered. In patients with calcified valves, 
the treatment of choice is valve replacement. The Ross proce-
dure has been suggested for patients of childbearing age and 
for those who want to avoid anticoagulation. Percutaneous 
valve implantation has become an alternative technique for 
treating stenosis of the pulmonary valve substitute (homo-
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graft). Transcatheter aortic valve implantation currently has 
no place in the treatment of congenital AS.
In our case, the stenosis was moderate and the patient re-
ferred with breathlessness and mild fatigue, no ascending 
aortic dilatation, and no left ventricle dysfunction; hence, we 
successfully treated the patient with medical therapy and pe-
riodical control by echocardiogram in our ambulatory.
The obstruction of LVOT, in particular subaortic membrane 
stenosis, is a rare and misdiagnosed disease, not to underes-
timate in adults.
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